Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:15:30 EDT Sun 31 May 2026
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR+ Search
SEDAR+ Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR+ Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News last 24 hour(s) - 24 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2026-05-31 08:06
U
U:RVMD
News Release
200
Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
2026-05-31 08:00
U
U:REPL
News Release
200
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
2026-05-31 08:00
U
U:PFE
News Release
200
Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
2026-05-31 08:00
U
U:LLY
News Release
200
Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
2026-05-31 08:00
U
U:IMCR
News Release
200
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
2026-05-31 08:00
U
U:GRAL
News Release
200
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri(TM) Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
2026-05-31 07:00
U
U:SMXW
News Release
200
SMX and the Age of Parity: Certified Recycling Becomes the New Economics of Plastic
2026-05-31 07:00
U
U:SMX
News Release
200
SMX and the Age of Parity: Certified Recycling Becomes the New Economics of Plastic
2026-05-30 22:45
U
U:ELEK
News Release
200
As Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
2026-05-30 22:15
U
U:FUN
News Release
200
SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER
2026-05-30 22:00
U
U:ELEK
News Release
200
Global EV Charging Patent Update: Elektros Inc. Continues To Advance and Protect Its Intellectual Property as EV Infrastructure Opportunities Expand Worldwide
2026-05-30 21:15
U
U:ELEK
News Release
200
Global Microcap Investors Are Discovering a Rare Diamond in the Rough
2026-05-30 20:42
U
U:AUMMF
News Release
200
Results of Annual General Meeting
2026-05-30 17:24
U
U:BAYZF
News Release
200
ASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 17:24
U
U:BAYRY
News Release
200
ASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 14:30
U
U:WHWK
News Release
200
Whitehawk Therapeutics Presents Real-World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
2026-05-30 14:30
U
U:PGEN
News Release
200
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
2026-05-30 14:30
U
U:EIKN
News Release
200
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
2026-05-30 14:15
U
U:BNTX
News Release
200
Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
2026-05-30 12:03
U
U:BWLP
News Release
200
BW LPG Enters Into Agreement for Eight 90'cbm Panamax Newbuildings with Hyundai Heavy Industries
2026-05-30 12:00
U
U:MIRM
News Release
200
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
2026-05-30 11:15
U
U:MLYS
News Release
200
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
2026-05-30 10:00
U
U:EXEL
News Release
200
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX(TM) (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
2026-05-30 08:30
U
U:TEM
News Release
200
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community